Assessment of the Impact of a Coenzyme Q10 Supplementation on the Skin

Status Completed

Clinical Trial Summary

Objective of the study is to determine the influence of dietary supplementation with coenzyme Q10 (CoQ10) on skin conditions. 33 healthy female subjects will be randomly assigned to a placebo group, a low-dose (LD) group receiving 50 mg CoQ10/day and a high-dose group (HD) receiving 150 mg CoQ10/day (11 subjects per group). A water-soluble form of CoQ10 with improved bioavailability (Quvital syrup with Q10vital®, Valens Int. d.o.o., Slovenia) will be used. Various skin parameters will be evaluated before the supplementation (the baseline), after 6 and after 12 weeks of supplementation. To evaluate the photoprotective potential of CoQ10 the minimal erythema dose (MED) will be determined before (the baseline) and after 12 weeks of the supplementation.

Clinical Trial Description

Objective of the study is to determine the influence of dietary supplementation of CoQ10 in form of water-soluble Q10vital® on skin conditions. 33 healthy female subjects will be randomly assigned to a placebo group, a low-dose (LD) group receiving 50 mg CoQ10/day and a high-dose group (HD) receiving 150 mg CoQ10/day (11 subjects per group). A water-soluble form of CoQ10 with improved bioavailability (Quvital syrup with Q10vital®, Valens Int. d.o.o., Slovenia) will be used. The placebo or CoQ10 will be administered in the form of a syrup; all subjects will consume 5 mL of syrup daily for 12 weeks. The photoprotective potential of CoQ10 will be evaluated with a determination of the minimal erythema dose (MED) before (the baseline) and after 12 weeks of the supplementation. Other skin parameters will be evaluated before supplementation (the baseline), after 6 and after 12 weeks of supplementation. Comparison will be done as the mean of the individual ratios. The differences between the before-after condition will be analyzed with the statistical test of analysis of variance. In case of failure to find homogeneity in the variances the nonparametric ANOVA, the Willcoxon test, will be used. The results will be expressed as mean ± standard error for each group with a significance level of 0.05 for all the statistical tests. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02604641
Study type	Interventional
Source	Higher School of Applied Sciences (VIST)
Contact
Status	Completed
Phase	N/A
Start date	October 2014
Completion date	May 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01984619` - Prospective Study Evaluating the Treatment of Hyperdynamic Forehead Wrinkles	N/A
Completed	`NCT01713985` - Feasibility Study: Evaluation of Ulthera Versus Thermage for Treating the Face and Neck	N/A
Recruiting	`NCT01586819` - Lateral Canthal Rhytides With Medium Depth Chemical Peel With or Without Pretreatment With Botulinum Toxin A	Phase 3
Completed	`NCT05254210` - Feasibility Study To Collect Safety And Preliminary Efficacy Data For A Radiofrequency Microneedling Device	N/A
Completed	`NCT01519934` - A Retrospective Study to Evaluate the Effectiveness of the Ulthera System	N/A
Completed	`NCT01460927` - TriActive+ Radiofrequency (RF) for Non-invasive Treatment of Wrinkles & Rhytides	N/A
Completed	`NCT03811756` - The Effect of 12-week Dietary Intake of Syrup Containing CoQ10 and Collagen on Dermis Density and Other Skin Parameters	N/A
Completed	`NCT04988412` - The Effect of 12-week Dietary Intake of Food Supplements Containing Collagen on Dermis Density and Other Skin Parameters	N/A
Completed	`NCT02913547` - Silk'n HST for Wrinkle Reduction - Clinical Study Protocol	N/A
Active, not recruiting	`NCT02019004` - A Pilot Study Testing Onabotulinum Toxin A Versus Incobotulinum Toxin A Injections for Facial Wrinkles	N/A
Completed	`NCT02340078` - A Clinical Study to Evaluate the Efficacy and Safety of YVOIRE Volume Plus Versus YVOIRE Volume in Nasolabial Fold Injection	N/A
Completed	`NCT01283464` - Comparison of Retinol 1.0% and Tretinoin 0.02% in the Treatment of Moderate to Severe Photodamage and Wrinkles	Phase 2
Completed	`NCT01034956` - Outcomes and Patient Experience After Soft Tissue Dermal Filler Injections	N/A
Completed	`NCT02425943` - Sculptra Aesthetic Post-Approval Study	Phase 4
Recruiting	`NCT05847530` - Pilot Evaluation of the Cynosure Potenza™ System for Treatment of Cosmetic Dermatologic Skin Conditions	N/A
Enrolling by invitation	`NCT01847066` - Epidermal Delivery of Ani-Aging Ingredients	N/A
Completed	`NCT01859611` - TriActive+ Radiofrequency (RF) for Non-Invasive Treatment of Wrinkles and Rhytides	N/A
Completed	`NCT01297634` - Radial Diffusion of the Botulinum Toxin Type A (Botox®): Electromyographic Evaluation of the Frontal Muscle	Phase 4
Completed	`NCT05011461` - The Effect of Topical Almond Oil vs. Topical Retinol on The Appearance of Facial Wrinkles	N/A
Completed	`NCT03460860` - Astaxanthin (2 mg) + Lycopene (1.8 mg) + D-Alpha-Tocopherol (10 IU) For The Treatment Of Skin Aging	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.